Selling the business to Frazier Healthcare Partners will allow the respiratory device maker to shift more resources to faster-growing parts of its portfolio.
Source: MedTech Dive
You may also like
Knee Pain? Ragged Cartilage? Research Suggests...
Lawmakers Look To Make Abortion Shield Laws Less...
Medtronic recalls heart valve delivery catheter for...
HistoSonics wins Europe’s CE mark for...
CVS Caremark reaches settlement with FTC over insulin...
HCA cuts 2026 earnings forecast on insurance coverage...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.